Infection Control (Disinfection & Sterilization) Global Market - Forecast to 2022
Healthcare associated infections which mainly includes hospital or community acquired infections are persisting factor in each and every healthcare system. Increase in occurrence of hospital acquired infections and advancements in sterilization and disinfection technologies are making the infection prevention and control market promising. For reduction of hospital acquired infections, infection prevention control organizations are applying epidemiologic and scientific principles and statistic analysis. Along with this, from the past decade there is a progressive refinement in sterilizing technologies from manually operated equipment to modern microprocessor controlled automatic machines. Plasma sterilization and use of electrostatics for surface disinfection are emerging and promising technologies in sterilizers and disinfectant market. Infection control products are used in a wide variety of applications like in healthcare settings, food and beverage industries, drug discovery, dental clinics and cosmetics. In recent times there is an advancement in sterilizing surgical tools in hospital settings by using robotic surgical tool sterilization process and thus promoting sufficient process of sterilization.
The global infection control market is expected to grow at a single digit high CAGR% to reach $22,582 million by 2022. Infection control market is mainly classified into products and end-users.
The infection control market by products is segmented into disinfection and sterilization. The disinfection market is further sub-segmented into the disinfectors which include washers, flushers and UV rays disinfectors, the endoscope reprocessors, the disinfectants and personal protective equipments (PPE). The disinfectants are divided by product type and EPA classification. Hand, skin, instrument and surface disinfectants are categorized under product type while low-level, intermediate level and high level disinfectants are divided under EPA classification segment. The personal protective equipment includes gloves and foot covers, surgical masks and respirators, surgical drapes and gowns, disinfectant wipes and others (protective eye-wears and sterilization wraps).
The infection control by sterilization is classified by methods and services. The sterilization market by method involves the heat sterilization which further includes wet/moist heat sterilization and dry sterilization, the low temperature sterilization including ethylene oxide sterilization (ETO), vaporized hydrogen peroxide (VHP), hydrogen peroxide gas plasma, peracetic acid, ozone gas, formaldehyde sterilization and chlorine dioxide, the filtration sterilization and the radiation sterilization contains ionizing and non-ionizing radiation. However the sterilization market by services is segmented into in-house sterilization services and contract sterilization services. Both the in-house and contract sterilization provides ethylene oxide sterilization, gamma sterilization, e-beam sterilization and other sterilization services.
The end-users of infection control market are pharmaceuticals, biotechnology, hospitals, research laboratories and others. The hospital end-user segment consists of dental clinics, nursing centres and ambulatory services, while the other end-users of this market are cosmetics, food and beverage and veterinary.
Among the products, disinfection segment holds the largest share and sterilization is the fastest growing segment from 2015 to 2022. By end-users, hospital is the largest segment and is the fastest segment from 2015 to 2022. Geographical wise, North America is the largest market, with a share of 39.5% followed by Europe, Asia and Rest of the World. The Asia region is the fastest growing region from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the Infection prevention and control market. Growth in the Asia-Pacific market is attributed to implementation of practical evidence based, low cost and simple preventive strategies, obtaining fund research projects via ICMR, DBT and state agencies and training infection control professionals and nurses.
The Infection Control market is expected to grow at a single digit high CAGR during 2015 to 2022. The factors driving the growth of this market are increase in aging population, rising occurrence of hospital acquired infections, increase in number of surgeries performed, proper maintenance of hygiene among hospital staff and increasing awareness among people. While rise in trend for e-beam radiation sterilization through service sterilization industry and growth of single use technology products in developing countries are some of the opportunities that are propelling the growth of the market. However stringent regulations and economic downturn and saturation are hampering the growth of the market.
The Infection Control global market is a highly fragmented market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the infection control market are 3M Company (U.S.), Advanced Sterilization Products (U.S.), Ansell Limited (Australia), Belimed (Switzerland), Cantel Medical (U.S.), Getinge Group (Sweden), Halyard Health (U.S.), Hartmann Group (Germany), Sterigenics International, Inc., (U.S.) and Steris Corporation (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
The global infection control market is expected to grow at a single digit high CAGR% to reach $22,582 million by 2022. Infection control market is mainly classified into products and end-users.
The infection control market by products is segmented into disinfection and sterilization. The disinfection market is further sub-segmented into the disinfectors which include washers, flushers and UV rays disinfectors, the endoscope reprocessors, the disinfectants and personal protective equipments (PPE). The disinfectants are divided by product type and EPA classification. Hand, skin, instrument and surface disinfectants are categorized under product type while low-level, intermediate level and high level disinfectants are divided under EPA classification segment. The personal protective equipment includes gloves and foot covers, surgical masks and respirators, surgical drapes and gowns, disinfectant wipes and others (protective eye-wears and sterilization wraps).
The infection control by sterilization is classified by methods and services. The sterilization market by method involves the heat sterilization which further includes wet/moist heat sterilization and dry sterilization, the low temperature sterilization including ethylene oxide sterilization (ETO), vaporized hydrogen peroxide (VHP), hydrogen peroxide gas plasma, peracetic acid, ozone gas, formaldehyde sterilization and chlorine dioxide, the filtration sterilization and the radiation sterilization contains ionizing and non-ionizing radiation. However the sterilization market by services is segmented into in-house sterilization services and contract sterilization services. Both the in-house and contract sterilization provides ethylene oxide sterilization, gamma sterilization, e-beam sterilization and other sterilization services.
The end-users of infection control market are pharmaceuticals, biotechnology, hospitals, research laboratories and others. The hospital end-user segment consists of dental clinics, nursing centres and ambulatory services, while the other end-users of this market are cosmetics, food and beverage and veterinary.
Among the products, disinfection segment holds the largest share and sterilization is the fastest growing segment from 2015 to 2022. By end-users, hospital is the largest segment and is the fastest segment from 2015 to 2022. Geographical wise, North America is the largest market, with a share of 39.5% followed by Europe, Asia and Rest of the World. The Asia region is the fastest growing region from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the Infection prevention and control market. Growth in the Asia-Pacific market is attributed to implementation of practical evidence based, low cost and simple preventive strategies, obtaining fund research projects via ICMR, DBT and state agencies and training infection control professionals and nurses.
The Infection Control market is expected to grow at a single digit high CAGR during 2015 to 2022. The factors driving the growth of this market are increase in aging population, rising occurrence of hospital acquired infections, increase in number of surgeries performed, proper maintenance of hygiene among hospital staff and increasing awareness among people. While rise in trend for e-beam radiation sterilization through service sterilization industry and growth of single use technology products in developing countries are some of the opportunities that are propelling the growth of the market. However stringent regulations and economic downturn and saturation are hampering the growth of the market.
The Infection Control global market is a highly fragmented market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the infection control market are 3M Company (U.S.), Advanced Sterilization Products (U.S.), Ansell Limited (Australia), Belimed (Switzerland), Cantel Medical (U.S.), Getinge Group (Sweden), Halyard Health (U.S.), Hartmann Group (Germany), Sterigenics International, Inc., (U.S.) and Steris Corporation (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.5 PRIMARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in aging population
3.3.1.2 Increase in number of surgeries performed
3.3.1.3 Rising occurrence of hospital acquired infections
3.3.1.4 Increasing awareness among people
3.3.1.5 Proper maintenance of hygiene among hospital staff
3.3.1.6 Rise in trend for e-beam radiation sterilization through service sterilization industry
3.3.1.7 Single use technology (medical non-woven) products, an opportunity especially in developing countries
3.3.2 RESTRAINTS & THREATS
3.3.2.1 Economic downturn and saturation of market in developed countries
3.3.2.2 High cost of robotic technologies
3.3.2.3 Stringent regulations
3.3.2.4 Availability of alternative technologies
3.3.3 CHALLENGES
3.3.3.1 Sterilization and disinfection of advanced medical instruments
3.4 PORTER’S FIVE FORCE ANALYSIS
3.4.1 THREAT OF NEW ENTRANTS
3.4.2 THREAT OF SUBSTITTES
3.4.3 BARGAINING POWER OF SUPPLIERS
3.4.4 BARGAINING POWER OF BUYERS
3.4.5 RIVALRY AMONG EXISTING COMPETITORS
3.5 REGULATORY GUIDELINES
3.5.1 UNITED STATES
3.5.2 EUROPE
3.5.3 CHINA
3.5.4 AUSTRALIA
3.6 PATENT TRENDS
3.7 INFECTIONS
3.7.1 MICROBIAL INFECTIONS
3.7.1.1 Bacterial infections
3.7.1.1.1 Mycobacterium tuberculosis
3.7.1.1.2 Clostridium difficile
3.7.1.1.3 Escherichia coli
3.7.1.1.4 Helicobacter pylori
3.7.1.1.5 Salmonella
3.7.1.1.6 Others
3.7.1.2 Viral infections
3.7.1.2.1 Ebola
3.7.1.2.2 Human immunodeficiency virus (HIV)
3.7.1.2.3 Herpes simplex virus
3.7.1.2.4 Yellow fever
3.7.1.2.5 Dengue fever
3.7.1.2.6 Others
3.7.1.3 Fungal infections
3.7.1.3.1 Cryptococcus gatti
3.7.1.3.2 Aspergillus
3.7.1.3.3 Pneumocystis jiroveci
3.7.1.3.4 Fungal keratitis
3.7.1.3.5 Dermatophytosis
3.7.1.3.6 Others
3.7.2 HEALTHCARE ASSOCIATED INFCETIONS (HCAI)
3.7.2.1 Hospital acquired infections (HAI)
3.7.2.1.1 Central-line associated bloodstream infection (CLABSI)
3.7.2.1.2 Catheter associated urinary tract infection (CAUTI)
3.7.2.1.3 Surgical site infection (SSI)
3.7.2.1.4 Ventilator-associated pneumonia infection (VAPI)
3.7.2.2 Community acquired infection
3.7.2.2.1 Methicillin-resistant staphylococcus aureus (MRSA) infection
3.7.2.2.2 Community acquired pneumonia
3.8 OTHER STERILIZATION AND DISINFECTION TECHNIQUES
3.8.1 SUPERCRITICAL CARBON-DIOXIDE TECHNOLOGY (SF-CO2)
3.8.2 NITROGEN DIOXIDES (NO2)
3.8.3 PULSED ELECTRICAL FIELD (PEF) STERILIZATION
3.8.4 MICROWAVE ENERGY STERILIZATION
3.8.5 PHOTOCATALYSIS
3.8.6 ULTRASONIC TECHNOLOGY
3.9 MARKET SHARE ANALYSIS
4 INFECTION CONTROL GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 DISINFECTION
4.2.1 INTRODUCTION
4.2.2 DISINFECTORS
4.2.2.1 Washer disinfectors
4.2.2.2 Flushers disinfectors
4.2.2.3 UV rays disinfectors
4.2.3 ENDOSCOPE REPROCESSORS
4.2.4 DISINFECTANTS
4.2.4.1 By product type
4.2.4.1.1 Hand
4.2.4.1.2 Skin
4.2.4.1.3 Surface
4.2.4.1.4 Instrument
4.2.4.2 By environmental protection agency (EPA) classification
4.2.4.2.1 Low-level disinfectants (LLD)
4.2.4.2.2 Intermediate-level disinfectants (ILD)
4.2.4.2.3 High-level disinfectants (HLD)
4.2.5 PERSONAL PROTECTIVE EQUIPMENTS
4.2.5.1 Gloves and foot covers
4.2.5.2 Surgical masks and respirators
4.2.5.3 Surgical drapes and gowns
4.2.5.4 Disinfectant wipes
4.2.5.5 Others
4.2.5.5.1 Protective eye-wears
4.2.5.5.2 Sterilization wraps
4.3 STERILIZATION
4.3.1 INTRODUCTION
4.3.2 STERILIZATION, BY METHOD
4.3.2.1 Heat sterilization
4.3.2.1.1 Wet/Moist heat sterilization
4.3.2.1.1.1 Vertical autoclave
4.3.2.1.1.2 Horizontal autoclave
4.3.2.1.1.3 Portable autoclave
4.3.2.1.2 Dry heat sterilization
4.3.2.1.3 Low temperature sterilization
4.3.2.1.3.1 Ethylene oxide sterilization
4.3.2.1.3.2 Hydrogen peroxide
4.3.2.1.3.3 Vapor hydrogen peroxide sterilization
4.3.2.1.3.4 Peracetic acid
4.3.2.1.3.5 Ozone gas
4.3.2.1.3.6 Formaldehyde sterilization
4.3.2.1.3.7 Chlorine dioxide sterilization
4.3.2.1.4 Filtration sterilization
4.3.2.1.5 Radiation sterilization
4.3.2.1.5.1 Ionizing radiation
4.3.2.1.5.2 Non-ionizing radiation
4.3.3 STERILIZATION BY SERVICES
4.3.3.1 In-house sterilization services
4.3.3.1.1 Ethylene oxide sterilization
4.3.3.1.2 E-beam sterilization
4.3.3.1.3 Gamma sterilization
4.3.3.1.4 Other in-house sterilization services
4.3.3.2 Contract sterilization services
4.3.3.2.1 Ethylene oxide sterilization
4.3.3.2.2 E-beam sterilization
4.3.3.2.3 Gamma sterilization
4.3.3.2.4 Other contract sterilization services
5 INFECTION CONTROL GLOBAL MARKET, BY END-USERS
5.1 INTRODUCTION
5.2 PHARMACEUTICALS
5.3 BIOTECHNOLOGY
5.4 HOSPITALS
5.4.1 DENTAL CLINICS
5.4.2 NURSING CENTERS
5.4.3 AMBULATORY SURGICAL CENTRES
5.5 RESEARCH LABORATORIES
5.6 OTHERS
5.6.1 COSMETICS
5.6.2 FOOD AND BEVERAGE
5.6.3 VETERINARY
6 REGIONAL ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.2.1 UNITED STATES
6.2.2 CANADA
6.3 EUROPE
6.4 ASIA-PACIFIC
6.4.1 INDIA
6.4.2 CHINA
6.4.3 JAPAN
6.5 REST OF THE WORLD
6.5.1 SOUTH AFRICA
6.5.2 MIDDLE EAST
7 COMPETITIVE LANDSCAPE
7.1 INTRODUCTION
7.2 NEW PRODUCT LAUNCHES
7.3 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES
7.4 APPROVALS
7.5 EXPANSIONS
7.6 MERGERS & ACQUISITIONS
8 MAJOR COMPANIES
8.1 3M COMPANY
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCT PORTFOLIO
8.1.4 KEY DEVELOPMENTS
8.1.5 BUSINESS STRATEGY
8.1.6 SWOT ANALYSIS
8.2 ANSELL LIMITED
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCT PORTFOLIO
8.2.4 KEY DEVELOPMENTS
8.2.5 BUSINESS STRATEGY
8.2.6 SWOT ANALYSIS
8.3 CANTEL MEDICAL
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCT PORTFOLIO
8.3.4 KEY DEVELOPMENTS
8.3.5 BUSINESS STRATEGY
8.3.6 SWOT ANALYSIS
8.4 GETINGE GROUP
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCT PORTFOLIO
8.4.4 KEY DEVELOPMENTS
8.4.5 BUSINESS STRATEGY
8.4.6 SWOT ANALYSIS
8.5 HALYARD HEALTH INC.
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCT PORTFOLIO
8.5.4 KEY DEVELOPMENTS
8.5.5 BUSINESS STRATEGY
8.5.6 SWOT ANALYSIS
8.6 HARTMANN
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCT PORTFOLIO
8.6.4 KEY DEVELOPMENTS
8.6.5 BUSINESS STRATEGY
8.6.6 SWOT ANALYSIS
8.7 JOHNSON & JOHNSON (ADVANCED STERILIZATION PRODUCTS)
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCT PORTFOLIO
8.7.4 KEY DEVELOPMENTS
8.7.5 BUSINESS STRATEGY
8.7.6 SWOT ANALYSIS
8.8 METALL ZUG (BELIMED)
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCT PORTFOLIO
8.8.4 KEY DEVELOPMENTS
8.8.5 BUSINESS STRATEGY
8.8.6 SWOT ANALYSIS
8.9 STERIGENICS INTERNATIONAL, INC.
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCT PORTFOLIO
8.9.4 KEY DEVELOPMENTS
8.9.5 BUSINESS STRATEGY
8.9.6 SWOT ANALYSIS
8.10 STERIS CORPORATION
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCT PORTFOLIO
8.10.4 KEY DEVELOPMENTS
8.10.5 BUSINESS STRATEGY
8.10.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.5 PRIMARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in aging population
3.3.1.2 Increase in number of surgeries performed
3.3.1.3 Rising occurrence of hospital acquired infections
3.3.1.4 Increasing awareness among people
3.3.1.5 Proper maintenance of hygiene among hospital staff
3.3.1.6 Rise in trend for e-beam radiation sterilization through service sterilization industry
3.3.1.7 Single use technology (medical non-woven) products, an opportunity especially in developing countries
3.3.2 RESTRAINTS & THREATS
3.3.2.1 Economic downturn and saturation of market in developed countries
3.3.2.2 High cost of robotic technologies
3.3.2.3 Stringent regulations
3.3.2.4 Availability of alternative technologies
3.3.3 CHALLENGES
3.3.3.1 Sterilization and disinfection of advanced medical instruments
3.4 PORTER’S FIVE FORCE ANALYSIS
3.4.1 THREAT OF NEW ENTRANTS
3.4.2 THREAT OF SUBSTITTES
3.4.3 BARGAINING POWER OF SUPPLIERS
3.4.4 BARGAINING POWER OF BUYERS
3.4.5 RIVALRY AMONG EXISTING COMPETITORS
3.5 REGULATORY GUIDELINES
3.5.1 UNITED STATES
3.5.2 EUROPE
3.5.3 CHINA
3.5.4 AUSTRALIA
3.6 PATENT TRENDS
3.7 INFECTIONS
3.7.1 MICROBIAL INFECTIONS
3.7.1.1 Bacterial infections
3.7.1.1.1 Mycobacterium tuberculosis
3.7.1.1.2 Clostridium difficile
3.7.1.1.3 Escherichia coli
3.7.1.1.4 Helicobacter pylori
3.7.1.1.5 Salmonella
3.7.1.1.6 Others
3.7.1.2 Viral infections
3.7.1.2.1 Ebola
3.7.1.2.2 Human immunodeficiency virus (HIV)
3.7.1.2.3 Herpes simplex virus
3.7.1.2.4 Yellow fever
3.7.1.2.5 Dengue fever
3.7.1.2.6 Others
3.7.1.3 Fungal infections
3.7.1.3.1 Cryptococcus gatti
3.7.1.3.2 Aspergillus
3.7.1.3.3 Pneumocystis jiroveci
3.7.1.3.4 Fungal keratitis
3.7.1.3.5 Dermatophytosis
3.7.1.3.6 Others
3.7.2 HEALTHCARE ASSOCIATED INFCETIONS (HCAI)
3.7.2.1 Hospital acquired infections (HAI)
3.7.2.1.1 Central-line associated bloodstream infection (CLABSI)
3.7.2.1.2 Catheter associated urinary tract infection (CAUTI)
3.7.2.1.3 Surgical site infection (SSI)
3.7.2.1.4 Ventilator-associated pneumonia infection (VAPI)
3.7.2.2 Community acquired infection
3.7.2.2.1 Methicillin-resistant staphylococcus aureus (MRSA) infection
3.7.2.2.2 Community acquired pneumonia
3.8 OTHER STERILIZATION AND DISINFECTION TECHNIQUES
3.8.1 SUPERCRITICAL CARBON-DIOXIDE TECHNOLOGY (SF-CO2)
3.8.2 NITROGEN DIOXIDES (NO2)
3.8.3 PULSED ELECTRICAL FIELD (PEF) STERILIZATION
3.8.4 MICROWAVE ENERGY STERILIZATION
3.8.5 PHOTOCATALYSIS
3.8.6 ULTRASONIC TECHNOLOGY
3.9 MARKET SHARE ANALYSIS
4 INFECTION CONTROL GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 DISINFECTION
4.2.1 INTRODUCTION
4.2.2 DISINFECTORS
4.2.2.1 Washer disinfectors
4.2.2.2 Flushers disinfectors
4.2.2.3 UV rays disinfectors
4.2.3 ENDOSCOPE REPROCESSORS
4.2.4 DISINFECTANTS
4.2.4.1 By product type
4.2.4.1.1 Hand
4.2.4.1.2 Skin
4.2.4.1.3 Surface
4.2.4.1.4 Instrument
4.2.4.2 By environmental protection agency (EPA) classification
4.2.4.2.1 Low-level disinfectants (LLD)
4.2.4.2.2 Intermediate-level disinfectants (ILD)
4.2.4.2.3 High-level disinfectants (HLD)
4.2.5 PERSONAL PROTECTIVE EQUIPMENTS
4.2.5.1 Gloves and foot covers
4.2.5.2 Surgical masks and respirators
4.2.5.3 Surgical drapes and gowns
4.2.5.4 Disinfectant wipes
4.2.5.5 Others
4.2.5.5.1 Protective eye-wears
4.2.5.5.2 Sterilization wraps
4.3 STERILIZATION
4.3.1 INTRODUCTION
4.3.2 STERILIZATION, BY METHOD
4.3.2.1 Heat sterilization
4.3.2.1.1 Wet/Moist heat sterilization
4.3.2.1.1.1 Vertical autoclave
4.3.2.1.1.2 Horizontal autoclave
4.3.2.1.1.3 Portable autoclave
4.3.2.1.2 Dry heat sterilization
4.3.2.1.3 Low temperature sterilization
4.3.2.1.3.1 Ethylene oxide sterilization
4.3.2.1.3.2 Hydrogen peroxide
4.3.2.1.3.3 Vapor hydrogen peroxide sterilization
4.3.2.1.3.4 Peracetic acid
4.3.2.1.3.5 Ozone gas
4.3.2.1.3.6 Formaldehyde sterilization
4.3.2.1.3.7 Chlorine dioxide sterilization
4.3.2.1.4 Filtration sterilization
4.3.2.1.5 Radiation sterilization
4.3.2.1.5.1 Ionizing radiation
4.3.2.1.5.2 Non-ionizing radiation
4.3.3 STERILIZATION BY SERVICES
4.3.3.1 In-house sterilization services
4.3.3.1.1 Ethylene oxide sterilization
4.3.3.1.2 E-beam sterilization
4.3.3.1.3 Gamma sterilization
4.3.3.1.4 Other in-house sterilization services
4.3.3.2 Contract sterilization services
4.3.3.2.1 Ethylene oxide sterilization
4.3.3.2.2 E-beam sterilization
4.3.3.2.3 Gamma sterilization
4.3.3.2.4 Other contract sterilization services
5 INFECTION CONTROL GLOBAL MARKET, BY END-USERS
5.1 INTRODUCTION
5.2 PHARMACEUTICALS
5.3 BIOTECHNOLOGY
5.4 HOSPITALS
5.4.1 DENTAL CLINICS
5.4.2 NURSING CENTERS
5.4.3 AMBULATORY SURGICAL CENTRES
5.5 RESEARCH LABORATORIES
5.6 OTHERS
5.6.1 COSMETICS
5.6.2 FOOD AND BEVERAGE
5.6.3 VETERINARY
6 REGIONAL ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.2.1 UNITED STATES
6.2.2 CANADA
6.3 EUROPE
6.4 ASIA-PACIFIC
6.4.1 INDIA
6.4.2 CHINA
6.4.3 JAPAN
6.5 REST OF THE WORLD
6.5.1 SOUTH AFRICA
6.5.2 MIDDLE EAST
7 COMPETITIVE LANDSCAPE
7.1 INTRODUCTION
7.2 NEW PRODUCT LAUNCHES
7.3 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES
7.4 APPROVALS
7.5 EXPANSIONS
7.6 MERGERS & ACQUISITIONS
8 MAJOR COMPANIES
8.1 3M COMPANY
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCT PORTFOLIO
8.1.4 KEY DEVELOPMENTS
8.1.5 BUSINESS STRATEGY
8.1.6 SWOT ANALYSIS
8.2 ANSELL LIMITED
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCT PORTFOLIO
8.2.4 KEY DEVELOPMENTS
8.2.5 BUSINESS STRATEGY
8.2.6 SWOT ANALYSIS
8.3 CANTEL MEDICAL
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCT PORTFOLIO
8.3.4 KEY DEVELOPMENTS
8.3.5 BUSINESS STRATEGY
8.3.6 SWOT ANALYSIS
8.4 GETINGE GROUP
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCT PORTFOLIO
8.4.4 KEY DEVELOPMENTS
8.4.5 BUSINESS STRATEGY
8.4.6 SWOT ANALYSIS
8.5 HALYARD HEALTH INC.
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCT PORTFOLIO
8.5.4 KEY DEVELOPMENTS
8.5.5 BUSINESS STRATEGY
8.5.6 SWOT ANALYSIS
8.6 HARTMANN
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCT PORTFOLIO
8.6.4 KEY DEVELOPMENTS
8.6.5 BUSINESS STRATEGY
8.6.6 SWOT ANALYSIS
8.7 JOHNSON & JOHNSON (ADVANCED STERILIZATION PRODUCTS)
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCT PORTFOLIO
8.7.4 KEY DEVELOPMENTS
8.7.5 BUSINESS STRATEGY
8.7.6 SWOT ANALYSIS
8.8 METALL ZUG (BELIMED)
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCT PORTFOLIO
8.8.4 KEY DEVELOPMENTS
8.8.5 BUSINESS STRATEGY
8.8.6 SWOT ANALYSIS
8.9 STERIGENICS INTERNATIONAL, INC.
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCT PORTFOLIO
8.9.4 KEY DEVELOPMENTS
8.9.5 BUSINESS STRATEGY
8.9.6 SWOT ANALYSIS
8.10 STERIS CORPORATION
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCT PORTFOLIO
8.10.4 KEY DEVELOPMENTS
8.10.5 BUSINESS STRATEGY
8.10.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 INFECTION CONTROL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 2 INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 3 INFECTION CONTROL GLOBAL MARKET REVENUE, BY ENDUSERS, (2014-2022) ($MN)
Table 4 INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 5 INFECTION CONTROL DISINFECTION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 6 INFECTION CONTROL DISINFECTION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 7 INFECTION CONTROL DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 8 INFECTION CONTROL DISINFECTORS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 9 INFECTION CONTROL WASHER DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 10 INFECTION CONTROL FLUSHER DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 11 INFECTION CONTROL UV RAYS DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 12 INFECTION CONTROL ENDOSCOPE REPROCESSORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 13 INFECTION CONTROL DISINFECTANTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 14 INFECTION CONTROL DISINFECTANTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 15 INFECTION CONTROL DISINFECTANT PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 16 INFECTION CONTROL DISINFECTANT PRODUCTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 17 INFECTION CONTROL HAND DISINFECTANTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 18 INFECTION CONTROL SKIN DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 19 INFECTION CONTROL SURFACE DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 20 INFECTION CONTROL INSTRUMENT DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 21 INFECTION CONTROL DISINFECTANTS EPA CLASSIFICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 22 INFECTION CONTROL DISINFECTANTS EPA CLASSIFICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 23 INFECTION CONTROL LOW-LEVEL DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 24 INFECTION CONTROL INTERMEDIATE-LEVEL DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 25 INFECTION CONTROL HIGH-LEVEL DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 26 INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 27 INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 28 INFECTION CONTROL GLOVES AND FOOT COVERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 29 INFECTION CONTROL SURGICAL MASKS AND RESPIRATORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 30 INFECTION CONTROL SURICAL DRAPES AND GOWNS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 31 INFECTION CONTROL DISINFECTANT WIPES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 32 INFECTION CONTROL OTHER PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 33 INFECTION CONTROL STERILIZATION PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 34 INFECTION CONTROL STERILIZATION PRODUCTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 35 INFECTION CONTROL STERILIZATION METHODS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 36 INFECTION CONTROL STERILIZATION METHODS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 37 INFECTION CONTROL HEAT STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 38 INFECTION CONTROL HEAT STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 39 INFECTION CONTROL WET/MOIST HEAT STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 40 INFECTION CONTROL WET/MOIST HEAT STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 41 INFECTION CONTROL VERTICAL AUTOCLAVE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 42 INFECTION CONTROL HORIZONTAL AUTOCLAVE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 43 INFECTION CONTROL PORTable AUTOCLAVE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 44 INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 45 INFECTION CONTROL LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 46 INFECTION CONTROL LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 47 INFECTION CONTROL ETHYLENE OXIDE LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 48 INFECTION CONTROL HYDROGEN PEROXIDE LOW TEMPERATURE STERILIZATIONGLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 49 INFECTION CONTROL VAPOR HYDROGEN PEROXIDE LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 50 INFECTION CONTROL PERACETIC ACID LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 51 INFECTION CONTROL OZONE GAS LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 52 INFECTION CONTROL FORMALDEHYDE LOW TEMPERATURE STERILZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 53 INFECTION CONTROL CHLORINE DIOXIDE LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 54 INFECTION CONTROL FILTRATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 55 INFECTION CONTROL RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 56 INFECTION CONTROL RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 57 INFECTION CONTROL IONIZING RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 58 INFECTION CONTROL NON-IONIZING RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 59 INFECTION CONTROL STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 60 INFECTION CONTROL STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 61 INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 62 INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 63 INFECTION CONTROL ETHYLENE OXIDE IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 64 INFECTION CONTROL E-BEAM IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 65 INFECTION CONTROL GAMMA IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 66 INFECTION CONTROL OTHER IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 67 INFECTION CONTROL CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 68 INFECTION CONTROL CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 69 INFECTION CONTROL ETHYLENE OXIDE CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 70 INFECTION CONTROL E-BEAM CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 71 INFECTION CONTROL GAMMA CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 72 INFECTION CONTROL OTHER CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 73 INFECTION CONTROL GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 74 INFECTION CONTROL PHARMACEUTICAL END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 75 INFECTION CONTROL BIOTECHNOLOGY END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 76 INFECTION CONTROL HOSPITAL END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 77 INFECTION CONTROL HOSPITAL END-USERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 78 INFECTION CONTROL DENTAL CLINIC END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 79 INFECTION CONTROL NURSING CENTRE END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 80 INFECTION CONTROL AMBULATORY SURGICAL CENTRE END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 81 INFECTION CONTROL RESEARCH LABORATORIES END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 82 INFECTION CONTROL OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 83 INFECTION CONTROL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 84 NORTH AMERICAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 85 NORTH AMERICAN INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 86 NORTH AMERICAN INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 87 NORTH AMERICAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 88 NORTH AMERICAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
Table 89 NORTH AMERICAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN)
Table 90 NORTH AMERICAN INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 91 NORTH AMERICAN INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 92 NORTH AMERICAN INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 93 NORTH AMERICAN INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 94 NORTH AMERICAN INFECTION CONTROL WET/MOIST HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 95 NORTH AMERICAN INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 96 NORTH AMERICAN INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 97 NORTH AMERICAN INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 98 NORTH AMERICAN INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 99 NORTH AMERICAN INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 100 NORTH AMERICAN INFECTION CONTROL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 101 NORTH AMERICAN INFECTION CONTROL HOSPITAL END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 102 EUROPEAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 103 EUROPEAN INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 104 EUROPEAN INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 105 EUROPEAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 106 EUROPEAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
Table 107 EUROPEAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN)
Table 108 EUROPEAN INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 109 EUROPEAN INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 110 EUROPEAN INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 111 EUROPEAN INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 112 EUROPEAN INFECTION CONTROL WET/MOIST STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 113 EUROPEAN INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 114 EUROPEAN INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 115 EUROPEAN INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 116 EUROPEAN INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 117 EUROPEAN INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 118 EUROPEAN INFECTION CONTROL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 119 EUROPEAN INFECTION CONTROL HOSPITAL END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 120 ASIA-PACIFIC INFECTION CONTROL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 121 ASIA-PACIFIC INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 122 ASIA-PACIFIC INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 123 ASIA-PACIFIC INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 124 ASIA-PACIFIC INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
Table 125 ASIA-PACIFIC INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN)
Table 126 ASIA-PACIFIC INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 127 ASIA-PACIFIC INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 128 ASIA-PACIFIC INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 129 ASIA-PACIFIC INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 130 ASIA-PACIFIC INFECTION CONTROL WET/MOIST STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 131 ASIA-PACIFIC INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 132 ASIA-PACIFIC INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 133 ASIA-PACIFIC INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 134 ASIA-PACIFIC INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 135 ASIA-PACIFIC INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 136 ASIA-PACIFIC INFECTION CONTROL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 137 ASIA-PACIFIC INFECTION CONTROL HOSPITAL END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 138 REST OF THE WORLD INFECTION CONTROL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 139 REST OF THE WORLD INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 140 REST OF THE WORLD INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 141 REST OF THE WORLD INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 142 REST OF THE WORLD INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
Table 143 REST OF THE WORLD INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN)
Table 144 REST OF THE WORLD INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 145 REST OF THE WORLD INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 146 REST OF THE WORLD INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 147 REST OF THE WORLD INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 148 REST OF THE WORLD INFECTION CONTROL WET/MOIST STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 149 REST OF THE WORLD INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 150 REST OF THE WORLD INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 151 REST OF THE WORLD INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 152 REST OF THE WORLD INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 153 REST OF THE WORLD INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 154 REST OF THE WORLD INFECTION CONTROL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 155 REST OF THE WORLD INFECTION CONTROL HOSPITAL ENDUSERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 156 NEW PRODUCT LAUNCHES (2014-2016)
Table 157 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES (2014-2016)
Table 158 APPROVALS (2014-2016)
Table 159 EXPANSIONS (2014-2016)
Table 160 MERGERS & ACQUISITIONS (2014-2016)
Table 161 3M COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 162 3M COMPANY: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 163 3M COMPANY: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 164 ANSELL LIMITED: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 165 ANSELL LIMITED: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 166 ANSELL LIMITED: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 167 CANTEL MEDICAL: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 168 CANTEL MEDICAL: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 169 CANTEL MEDICAL: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 170 GETINGE GROUPS: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 171 GETINGE GROUPS: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 172 HALYARD HEALTH INC,: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 173 HALYARD HEALTH INC,: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 174 HALYARD HEALTH INC,: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 175 HARTMANN: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 176 HARTMANN: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 177 HARTMANN: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 178 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 179 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 180 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 181 METALL ZUG: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 182 METALL ZUG: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 183 METALL ZUG: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 184 STERIS CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 185 STERIS CORPORATION: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 186 STERIS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 1 INFECTION CONTROL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 2 INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 3 INFECTION CONTROL GLOBAL MARKET REVENUE, BY ENDUSERS, (2014-2022) ($MN)
Table 4 INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 5 INFECTION CONTROL DISINFECTION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 6 INFECTION CONTROL DISINFECTION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 7 INFECTION CONTROL DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 8 INFECTION CONTROL DISINFECTORS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 9 INFECTION CONTROL WASHER DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 10 INFECTION CONTROL FLUSHER DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 11 INFECTION CONTROL UV RAYS DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 12 INFECTION CONTROL ENDOSCOPE REPROCESSORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 13 INFECTION CONTROL DISINFECTANTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 14 INFECTION CONTROL DISINFECTANTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 15 INFECTION CONTROL DISINFECTANT PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 16 INFECTION CONTROL DISINFECTANT PRODUCTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 17 INFECTION CONTROL HAND DISINFECTANTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 18 INFECTION CONTROL SKIN DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 19 INFECTION CONTROL SURFACE DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 20 INFECTION CONTROL INSTRUMENT DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 21 INFECTION CONTROL DISINFECTANTS EPA CLASSIFICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 22 INFECTION CONTROL DISINFECTANTS EPA CLASSIFICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 23 INFECTION CONTROL LOW-LEVEL DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 24 INFECTION CONTROL INTERMEDIATE-LEVEL DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 25 INFECTION CONTROL HIGH-LEVEL DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 26 INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 27 INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 28 INFECTION CONTROL GLOVES AND FOOT COVERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 29 INFECTION CONTROL SURGICAL MASKS AND RESPIRATORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 30 INFECTION CONTROL SURICAL DRAPES AND GOWNS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 31 INFECTION CONTROL DISINFECTANT WIPES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 32 INFECTION CONTROL OTHER PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 33 INFECTION CONTROL STERILIZATION PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 34 INFECTION CONTROL STERILIZATION PRODUCTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 35 INFECTION CONTROL STERILIZATION METHODS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 36 INFECTION CONTROL STERILIZATION METHODS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 37 INFECTION CONTROL HEAT STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 38 INFECTION CONTROL HEAT STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 39 INFECTION CONTROL WET/MOIST HEAT STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 40 INFECTION CONTROL WET/MOIST HEAT STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 41 INFECTION CONTROL VERTICAL AUTOCLAVE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 42 INFECTION CONTROL HORIZONTAL AUTOCLAVE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 43 INFECTION CONTROL PORTable AUTOCLAVE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 44 INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 45 INFECTION CONTROL LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 46 INFECTION CONTROL LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 47 INFECTION CONTROL ETHYLENE OXIDE LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 48 INFECTION CONTROL HYDROGEN PEROXIDE LOW TEMPERATURE STERILIZATIONGLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 49 INFECTION CONTROL VAPOR HYDROGEN PEROXIDE LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 50 INFECTION CONTROL PERACETIC ACID LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 51 INFECTION CONTROL OZONE GAS LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 52 INFECTION CONTROL FORMALDEHYDE LOW TEMPERATURE STERILZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 53 INFECTION CONTROL CHLORINE DIOXIDE LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 54 INFECTION CONTROL FILTRATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 55 INFECTION CONTROL RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 56 INFECTION CONTROL RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
Table 57 INFECTION CONTROL IONIZING RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 58 INFECTION CONTROL NON-IONIZING RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 59 INFECTION CONTROL STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 60 INFECTION CONTROL STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 61 INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 62 INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 63 INFECTION CONTROL ETHYLENE OXIDE IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 64 INFECTION CONTROL E-BEAM IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 65 INFECTION CONTROL GAMMA IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 66 INFECTION CONTROL OTHER IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 67 INFECTION CONTROL CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 68 INFECTION CONTROL CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 69 INFECTION CONTROL ETHYLENE OXIDE CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 70 INFECTION CONTROL E-BEAM CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 71 INFECTION CONTROL GAMMA CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 72 INFECTION CONTROL OTHER CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 73 INFECTION CONTROL GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 74 INFECTION CONTROL PHARMACEUTICAL END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 75 INFECTION CONTROL BIOTECHNOLOGY END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 76 INFECTION CONTROL HOSPITAL END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 77 INFECTION CONTROL HOSPITAL END-USERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 78 INFECTION CONTROL DENTAL CLINIC END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 79 INFECTION CONTROL NURSING CENTRE END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 80 INFECTION CONTROL AMBULATORY SURGICAL CENTRE END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 81 INFECTION CONTROL RESEARCH LABORATORIES END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 82 INFECTION CONTROL OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 83 INFECTION CONTROL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 84 NORTH AMERICAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 85 NORTH AMERICAN INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 86 NORTH AMERICAN INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 87 NORTH AMERICAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 88 NORTH AMERICAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
Table 89 NORTH AMERICAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN)
Table 90 NORTH AMERICAN INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 91 NORTH AMERICAN INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 92 NORTH AMERICAN INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 93 NORTH AMERICAN INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 94 NORTH AMERICAN INFECTION CONTROL WET/MOIST HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 95 NORTH AMERICAN INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 96 NORTH AMERICAN INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 97 NORTH AMERICAN INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 98 NORTH AMERICAN INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 99 NORTH AMERICAN INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 100 NORTH AMERICAN INFECTION CONTROL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 101 NORTH AMERICAN INFECTION CONTROL HOSPITAL END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 102 EUROPEAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 103 EUROPEAN INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 104 EUROPEAN INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 105 EUROPEAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 106 EUROPEAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
Table 107 EUROPEAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN)
Table 108 EUROPEAN INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 109 EUROPEAN INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 110 EUROPEAN INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 111 EUROPEAN INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 112 EUROPEAN INFECTION CONTROL WET/MOIST STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 113 EUROPEAN INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 114 EUROPEAN INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 115 EUROPEAN INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 116 EUROPEAN INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 117 EUROPEAN INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 118 EUROPEAN INFECTION CONTROL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 119 EUROPEAN INFECTION CONTROL HOSPITAL END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 120 ASIA-PACIFIC INFECTION CONTROL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 121 ASIA-PACIFIC INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 122 ASIA-PACIFIC INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 123 ASIA-PACIFIC INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 124 ASIA-PACIFIC INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
Table 125 ASIA-PACIFIC INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN)
Table 126 ASIA-PACIFIC INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 127 ASIA-PACIFIC INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 128 ASIA-PACIFIC INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 129 ASIA-PACIFIC INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 130 ASIA-PACIFIC INFECTION CONTROL WET/MOIST STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 131 ASIA-PACIFIC INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 132 ASIA-PACIFIC INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 133 ASIA-PACIFIC INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 134 ASIA-PACIFIC INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 135 ASIA-PACIFIC INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 136 ASIA-PACIFIC INFECTION CONTROL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 137 ASIA-PACIFIC INFECTION CONTROL HOSPITAL END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 138 REST OF THE WORLD INFECTION CONTROL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
Table 139 REST OF THE WORLD INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 140 REST OF THE WORLD INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 141 REST OF THE WORLD INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 142 REST OF THE WORLD INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
Table 143 REST OF THE WORLD INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN)
Table 144 REST OF THE WORLD INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 145 REST OF THE WORLD INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 146 REST OF THE WORLD INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 147 REST OF THE WORLD INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 148 REST OF THE WORLD INFECTION CONTROL WET/MOIST STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 149 REST OF THE WORLD INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 150 REST OF THE WORLD INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 151 REST OF THE WORLD INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 152 REST OF THE WORLD INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 153 REST OF THE WORLD INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 154 REST OF THE WORLD INFECTION CONTROL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 155 REST OF THE WORLD INFECTION CONTROL HOSPITAL ENDUSERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
Table 156 NEW PRODUCT LAUNCHES (2014-2016)
Table 157 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES (2014-2016)
Table 158 APPROVALS (2014-2016)
Table 159 EXPANSIONS (2014-2016)
Table 160 MERGERS & ACQUISITIONS (2014-2016)
Table 161 3M COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 162 3M COMPANY: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 163 3M COMPANY: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 164 ANSELL LIMITED: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 165 ANSELL LIMITED: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 166 ANSELL LIMITED: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 167 CANTEL MEDICAL: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 168 CANTEL MEDICAL: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 169 CANTEL MEDICAL: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 170 GETINGE GROUPS: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 171 GETINGE GROUPS: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 172 HALYARD HEALTH INC,: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 173 HALYARD HEALTH INC,: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 174 HALYARD HEALTH INC,: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 175 HARTMANN: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 176 HARTMANN: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 177 HARTMANN: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 178 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 179 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 180 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 181 METALL ZUG: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 182 METALL ZUG: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 183 METALL ZUG: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
Table 184 STERIS CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 185 STERIS CORPORATION: TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN)
Table 186 STERIS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)
LIST OF FIGURES
Figure 1 INFECTION CONTROL GLOBAL MARKET SHARE AND REVENUE, BY REGION, (2014-2022) ($MN)
Figure 2 INFECTION CONTROL GLOBAL MARKET: RESEARCH APPROACH
Figure 3 INFECTION CONTROL GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 INFECTION CONTROL GLOBAL MARKET: FORECASTING MODEL
Figure 5 INFECTION CONTROL GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
Figure 6 INFECTION CONTROL GLOBAL MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 INFECTION CONTROL GLOBAL MARKET: PORTER’S ANALYSIS
Figure 9 INFECTION CONTROL GLOBAL MARKET: PCT PATENT FILING BY MAJOR PLAYERS (2011-2016)
Figure 10 INFECTION CONTROL GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 11 INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS, (2015 V’S 2022) ($MN)
Figure 12 INFECTION CONTROL DISINFECTION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 13 INFECTION CONTROL DISINFECTORS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 14 INFECTION CONTROL DISINFECTANTS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 15 DISINFECTANTS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 16 DISINFECTANTS EPA CLASSIFICATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 17 PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY TYPE, (2015) (%)
Figure 18 INFECTION CONTROL STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 19 INFECTION CONTROL STERILIZATION GLOBAL MARKET REVENUE, BY METHODS, (2015 V’S 2022) ($MN)
Figure 20 INFECTION CONTROL HEAT STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 21 LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015) (%)
Figure 22 INFECTION CONTROL RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 23 INFECTION CONTROL STERILIZATION GLOBAL MARKET REVENUE, BY SERVICES, (2015 V’S 2022) ($MN)
Figure 24 INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 25 INFECTION CONTROL CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 26 INFECTION CONTROL GLOBAL MARKET REVENUE, BY END-USERS, (2015 V’S 2022) ($MN)
Figure 27 HOSPITALS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 28 INFECTION CONTROL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN), (CAGR %)
Figure 29 NORTH AMERICAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN)
Figure 30 NORTH AMERICAN DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 31 EUROPEAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN)
Figure 32 EUROPEAN DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 33 ASIA-PACIFIC INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN)
Figure 34 ASIA-PACIFIC DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 35 REST OF THE WORLD INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN)
Figure 36 REST OF THE WORLD DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 37 KEY GROWTH STRATEGIES, (2014 – 2016)
Figure 38 SWOT: 3M COMPANY
Figure 39 SWOT: ANSELL LIMITED
Figure 40 SWOT: CANTEL MEDICAL
Figure 41 SWOT: GETINGE GROUP
Figure 42 SWOT: HALYARD HEALTH INC.
Figure 43 SWOT: HARTMANN GROUP
Figure 44 SWOT: JOHNSON & JOHNSON
Figure 45 SWOT: BELIMED
Figure 46 SWOT: STERIGENICS INTERNATIONAL INC.
Figure 47 SWOT: STERIS CORPORATION
Figure 1 INFECTION CONTROL GLOBAL MARKET SHARE AND REVENUE, BY REGION, (2014-2022) ($MN)
Figure 2 INFECTION CONTROL GLOBAL MARKET: RESEARCH APPROACH
Figure 3 INFECTION CONTROL GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 INFECTION CONTROL GLOBAL MARKET: FORECASTING MODEL
Figure 5 INFECTION CONTROL GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
Figure 6 INFECTION CONTROL GLOBAL MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 INFECTION CONTROL GLOBAL MARKET: PORTER’S ANALYSIS
Figure 9 INFECTION CONTROL GLOBAL MARKET: PCT PATENT FILING BY MAJOR PLAYERS (2011-2016)
Figure 10 INFECTION CONTROL GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 11 INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS, (2015 V’S 2022) ($MN)
Figure 12 INFECTION CONTROL DISINFECTION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 13 INFECTION CONTROL DISINFECTORS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 14 INFECTION CONTROL DISINFECTANTS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 15 DISINFECTANTS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 16 DISINFECTANTS EPA CLASSIFICATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 17 PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY TYPE, (2015) (%)
Figure 18 INFECTION CONTROL STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 19 INFECTION CONTROL STERILIZATION GLOBAL MARKET REVENUE, BY METHODS, (2015 V’S 2022) ($MN)
Figure 20 INFECTION CONTROL HEAT STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 21 LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015) (%)
Figure 22 INFECTION CONTROL RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 23 INFECTION CONTROL STERILIZATION GLOBAL MARKET REVENUE, BY SERVICES, (2015 V’S 2022) ($MN)
Figure 24 INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 25 INFECTION CONTROL CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 26 INFECTION CONTROL GLOBAL MARKET REVENUE, BY END-USERS, (2015 V’S 2022) ($MN)
Figure 27 HOSPITALS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 28 INFECTION CONTROL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN), (CAGR %)
Figure 29 NORTH AMERICAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN)
Figure 30 NORTH AMERICAN DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 31 EUROPEAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN)
Figure 32 EUROPEAN DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 33 ASIA-PACIFIC INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN)
Figure 34 ASIA-PACIFIC DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 35 REST OF THE WORLD INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN)
Figure 36 REST OF THE WORLD DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
Figure 37 KEY GROWTH STRATEGIES, (2014 – 2016)
Figure 38 SWOT: 3M COMPANY
Figure 39 SWOT: ANSELL LIMITED
Figure 40 SWOT: CANTEL MEDICAL
Figure 41 SWOT: GETINGE GROUP
Figure 42 SWOT: HALYARD HEALTH INC.
Figure 43 SWOT: HARTMANN GROUP
Figure 44 SWOT: JOHNSON & JOHNSON
Figure 45 SWOT: BELIMED
Figure 46 SWOT: STERIGENICS INTERNATIONAL INC.
Figure 47 SWOT: STERIS CORPORATION
